P3 Health Partners PIII Cash Flow Statement (2019-2026)

NASDAQ PIII
$9.18 -0.23 (-2.44%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

P3 Health Partners Quarterly Cash Flow Statement

Periods 23 quarters
Latest Jun 2026

P3 Health Partners cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 23 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-29.46M-32.05M-26.27M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Share-based CompensationStock Comp.
0.56M0.36M6.85M11.71M3.72M1.78M2.19M0.98M1.03M2.25M2.96M1.45M1.62M1.96M0.72M1.81M1.46M1.21M1.10M
Gains from Investment SecuritiesGains Investment
9.89M-5.52M5.86M-11.81M2.57M-6.48M-0.65M1.73M-0.76M-0.76M-0.22M-8.67M-5.74M-7.49M-3.32M-2.00M2.54M-5.07M16.37M
Cash from OperationsCash from Ops.
-21.01M-5.70M-27.78M-45.31M-20.98M-31.95M-23.72M-28.84M-7.59M-15.88M-20.03M-10.24M-22.62M-57.24M-33.47M-16.63M-15.41M-25.73M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.31M0.31M0.21M
Amortization of Deferred ChargesAmort. Deferred Charges
0.18M0.18M1.27M0.28M0.06M0.07M0.07M-0.14M0.05M0.10M0.07M0.33M0.07M10.98M2.17M
Depreciation & Amortization (CF)Dep. & Amort.
0.43M0.46M21.75M21.72M21.82M22.00M21.54M21.78M21.72M21.63M21.54M21.69M21.67M21.15M21.05M21.08M21.03M21.00M21.04M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.14M0.04M-0.81M1.18M1.25M
Change in Account PayablesChange Payables
-1.09M4.61M4.02M-2.86M3.40M
Change in Accured ExpensesChange Accured Exp.
-3.52M6.60M4.02M-7.06M7.60M1.52M8.32M-3.69M2.47M8.90M-5.55M13.81M-6.48M-9.88M5.61M0.59M1.59M3.32M
Other Working Capital ChangesOther WC Changes
0.36M-3.03M-0.22M-1.67M-1.57M
Investing Activities
Capital ExpendituresCapex
1.23M1.11M0.88M0.52M0.88M-0.05M1.36M0.29M0.39M-0.21M0.02M-0.08M0.06M0.04M14.35M0.12M-2.19M-8.75M
Sales of Property, Plant and EquipmentPP&E (Sale)
14.53M
Acquisitions
4.93M
Cash from Investing ActivitiesCash from Investing
-1.01M-6.15M-1.15M-0.25M-6.38M0.05M-0.46M-1.19M-0.39M0.21M15.00M-0.47M0.05M-0.12M0.20M
Financing Activities
Other financing activitiesOther financing
6.33M-6.33M-0.09M-0.65M-1.69M-0.05M
Cash from Financing ActivitiesCash from Financing
12.54M-0.02M-1.21M-1.24M-1.18M15.00M14.10M87.16M-0.09M-0.84M11.40M56.14M-2.49M33.72M30.66M14.62M14.67M12.87M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.95M2.03M3.59M
Additional items
Change in Cash
-9.48M-11.86M-30.13M-46.80M-28.54M-16.90M-10.08M57.13M-8.06M-16.51M-8.63M45.90M-10.10M-24.00M-2.81M-1.97M-0.86M-12.65M
Free Cash FlowFCF
-22.24M-6.80M-28.65M-45.84M-21.86M-31.90M-25.09M-29.13M-7.97M-15.67M-20.05M-10.16M-22.68M-57.28M-47.81M-16.75M-13.22M-16.98M
Net Cash FlowNCF
-9.48M-11.86M-30.13M-46.80M-28.54M-16.90M-10.08M57.13M-8.06M-16.51M-8.63M45.90M-10.10M-24.00M-2.81M-1.97M-0.86M-12.65M